|
|
|
Intelligent Bio Solutions Inc (NASDAQ: INBS) |
|
Intelligent Bio Solutions Inc
Officers & Directors
Harry Simeonidis Chief Executive Officer and President (Principal Executive Officer) Spiro Sakiris Chief Financial Officer (Principal Financial Officer) Jason Isenberg Director Nicola Fraser Director Steven Boyages Chairman of the Board Jonathan Hurd Director ,
Intelligent Bio Solutions Inc currently has 13 employees.
News about Intelligent Bio Solutions Inc Key Personnel |
Intelligent Bio Solutions Inc. Reports Impressive Customer Employee Growth and Stock Performance Amid Financial Challenges
In a recent announcement, Intelligent Bio Solutions Inc. (NASDAQ: INBS) revealed a remarkable expansion in its customer employee base, with a staggering 118% year-over-year increase. The company, renowned for its innovative non-invasive drug testing technology, now estimates its total number of employees across its customer base to be approximately 1.4 million.
This significant growth represents a testament to Intelligent Bio Solutions Inc. s position as a leader in its field. By providing cutting-edge solutions in drug testing technology, the company has evidently garnered sign...
|
Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth Initiatives
New York, June 13, 2024 - Intelligent Bio Solutions Inc. (Nasdaq: INBS), a medical technology company specializing in intelligent, rapid, non-invasive testing solutions, has recently announced the implementation of a strategic reorganization and productivity plan. This comprehensive plan aims to support the company s global growth initiatives and enhance its overall performance.
With the healthcare sector experiencing rapid advancements and increasing demand for innovative medical solutions, Intelligent Bio Solutions recognizes the need for a robust strategy to ensure its long-term success. Th...
|
Intelligent Bio Solutions Inc. (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, has revealed key performance indicators from its operations in the United Kingdom. These indicators have contributed to the company s growth as the drug screening industry continues to battle drug test cheating and seeks simpler, faster, non-invasive, and more cost-effective solutions.
During the twelve months ending in the second quarter of 2024, Intelligent Bio Solutions Inc. recorded a cumulative net loss of $-13 million, resulting in a negative return on investment (ROI) of -322.78%. This figure places the company below 332 other healthcare sector companies t...
|
Intelligent Bio Solutions Inc. Achieves Remarkable Revenue Growth and Successful Public Offering, Fueling Advancement in Healthcare Technologies
New York, - Intelligent Bio Solutions Inc. (Nasdaq: INBS), a trailblazing medical technology company specializing in intelligent, rapid, and non-invasive testing solutions, has reported impressive unaudited revenue results for its fiscal third quarter and nine-month period, ended March 31, 2024. The year-over-year unaudited revenue soared by 80% for the third quarter and a remarkable 193% for the nine months, showcasing the company s consistent growth trajectory. Moreover, the third quarter witnessed the highest quarterly cartridge sales since the Intelligent F...
|
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
